What is ADMA Biologics's other working capital?

ADMA Biologics (ADMA) reported other working capital of 0.3% in Q4 2025.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

ADMA Biologics ADMA Other Working Capital

Other Working Capital at other companies

AbCellera Biologics Inc.ABCL

-$2.38M-7.4%

AnaptysBio, Inc.ANAB

-$8.1M+64.6%

Quest DiagnosticsDGX

$31M+163%

BiohavenBHVN

$837K-70.6%

AmgenAMGN

$67M+34.0%

AbbottABT

$420M-3.7%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's other working capital?: ADMA Biologics (ADMA) reported other working capital of 0.3% in Q4 2025.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.